Original news and analysis on international IP policy
A set of documents in use by today's closed-door negotiations on research and development for neglected diseases at the World Health Assembly lay out the core differences between WHO members. Negotiations are expected to last into the night as members try to agree on how to take forward recommendations from a key report - including to negotiate a binding convention on R&D for diseases left behind in the marketplace.
Members of the World Health Organization tonight will consider a draft decision on how the organisation will address the prevention and control of noncommunicable diseases, such as tobacco use, unhealthy diet, physical inactivity and harmful use of alcohol.
A drafting group has embarked on the task of combining four different proposals on the table at the annual World Health Assembly aimed at financing research and development for neglected diseases mostly afflicting poorer populations.
Members of the World Health Organization at their annual meeting tomorrow will address proposals for ways to finance research and development for diseases which afflict mainly developing countries but for which there are not lucrative markets.
The annual World Health Assembly being held this week has a rare chance to achieve a breakthrough on health research for the global poor if it can agree to move forward on a proposed convention, proponents said at a recent meeting.
BOSTON - Early stage innovation is still strong in the United States, but parties need to work better together and address bottlenecks in the middle stages, a panel of university and private sector experts said this week. Meanwhile, the president of global biotechnology company Genzyme said the industry is not in crisis and the company is hopeful about its recent merger with Sanofi.
The Drugs for Neglected Diseases initiative (DNDi) has released a policy brief in support of the proposed R&D convention to be considered at the upcoming World Health Assembly.
A senior official at the World Intellectual Property Organization recently sent an internal letter to WIPO Director General Francis Gurry announcing that he would be undertaking a fast, depriving himself of food during a period of reflection in protest of his treatment as staff after more than two decades there. And while the complaint is a personal one, the official’s letter brings attention to the sometimes uncomfortable strategic realignment taking place at the UN agency.
Switzerland has postponed signature of the Anti-Counterfeiting Trade Agreement (ACTA) until it has more information from several ongoing processes in Europe, the government said yesterday.
As World Intellectual Property Organization members engage this week in discussions about the extent of change to the UN agency’s development orientation, a new substantive proposal for reform has been put forward based on an external review of WIPO technical assistance.
The United Nations World Intellectual Property Organization is by its nature a crossroads of IP technical expertise and global public policy wrangling. But the difference between the two became more pronounced at last week’s meeting of the WIPO Standards Committee, according to participants.
A new draft proposal suggests that World Health Organization members postpone negotiations for a convention on financing of research and development for diseases predominantly afflicting poor populations. The negotiation of a convention is up for discussion by members at the annual World Health Assembly this month.